Monarch Partners Asset Management LLC Collegium Pharmaceutical, Inc Transaction History
Monarch Partners Asset Management LLC
- $328 Million
- Q4 2022
A detailed history of Monarch Partners Asset Management LLC transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Monarch Partners Asset Management LLC holds 179,129 shares of COLL stock, worth $5.22 Million. This represents 1.27% of its overall portfolio holdings.
Number of Shares
179,129
Previous 178,766
0.2%
Holding current value
$5.22 Million
Previous $2.86 Million
45.08%
% of portfolio
1.27%
Previous 0.86%
Shares
16 transactions
Others Institutions Holding COLL
# of Institutions
255Shares Held
36.9MCall Options Held
100KPut Options Held
21.1K-
Black Rock Inc. New York, NY5.79MShares$169 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.64MShares$76.8 Million1.79% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.59MShares$75.5 Million0.24% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.35MShares$68.4 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.66MShares$48.3 Million0.1% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $995M
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...